Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 31 AL 45

Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline

Palmer K, Lupo F, Perri R, Salamone G, Fadda L, Caltagirone C, Musicco M, Cravello L.

J Alzheimers Dis. 2011;24(1):35-45. doi: 10.3233/JAD-2010-101836.

BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease

Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Cortini F, Serpente M, Cantoni C, Fumagalli G, Ridolfi E, Cappa S, Binetti G, Franceschi M, Rainero I, Giordana MT, Mariani C, Bresolin N, Scarpini E, Galimberti D.

J Alzheimers Dis. 2011;23(4):701-7. doi: 10.3233/JAD-2010-101416.

Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer's disease

Qian W, Yin X, Hu W, Shi J, Gu J, Grundke-Iqbal I, Iqbal K, Gong CX, Liu F.

J Alzheimers Dis. 2011;23(4):617-27. doi: 10.3233/JAD-2010-100987.

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months

Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C.

Int J Geriatr Psychiatry. 2011 Jan;26(1):75-82. doi: 10.1002/gps.2491.

Immunotherapy for Alzheimer's disease

Morgan D.

J Intern Med. 2011 Jan;269(1):54-63. doi: 10.1111/j.1365-2796.2010.02315.x.

Homeostatic disinhibition in the aging brain and Alzheimer's disease

Gleichmann M, Chow VW, Mattson MP.

J Alzheimers Dis. 2011;24(1):15-24. doi: 10.3233/JAD-2010-101674.

PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease

Sabbagh MN, Agro A, Bell J, Aisen PS, Schweizer E, Galasko D.

Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):206-12. doi: 10.1097/WAD.0b013e318204b550.

"A feeling that you're helping": proxy decision making for Alzheimer's research

Dunn LB, Hoop JG, Misra S, Fisher SR, Roberts LW.

Narrat Inq Bioeth. 2011 Fall;1(2):107-22. doi: 10.1353/nib.2011.0034.

Oral silicon supplementation: an effective therapy for preventing oral aluminum absorption and retention in mammals

Domingo JL, Gómez M, Colomina MT.

Nutr Rev. 2011 Jan;69(1):41-51. doi: 10.1111/j.1753-4887.2010.00360.x.

Therapeutic targets in Alzheimer's disease and related tauopathies

Corbo CP, Alonso Adel C.

Prog Mol Biol Transl Sci. 2011;98:47-83. doi: 10.1016/B978-0-12-385506-0.00002-8.

What spouse caregivers know about communication in Alzheimer's disease: development of the AD Communication Knowledge Test

Williams CL.

Issues Ment Health Nurs. 2011;32(1):28-34. doi: 10.3109/01612840.2010.521292.

[Pathological changes induced by amyloid-β in Alzheimer's disease]

Takata K, Kitamura Y, Taniguchi T.

Yakugaku Zasshi. 2011 Jan;131(1):3-11. doi: 10.1248/yakushi.131.3.

Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease

Herrera JL, Diaz M, Hernández-Fernaud JR, Salido E, Alonso R, Fernández C, Morales A, Marin R.

J Neurochem. 2011 Mar;116(5):820-7. doi: 10.1111/j.1471-4159.2010.06987.x. Epub 2011 Jan 7.

Pathological significance of ganglioside clusters in Alzheimer's disease

Yanagisawa K.

J Neurochem. 2011 Mar;116(5):806-12. doi: 10.1111/j.1471-4159.2010.07006.x. Epub 2011 Jan 7.

Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease

Lee JC, Simonyi A, Sun AY, Sun GY.

J Neurochem. 2011 Mar;116(5):813-9. doi: 10.1111/j.1471-4159.2010.07033.x. Epub 2011 Jan 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias